1024 PHARMACODYNAMIC DEMONSTRATION OF IMMUNOLOGICAL TOLERANCE INDUCED BY KAN-101, A NOVEL LIVER-TARGETED THERAPY FOR CELIAC DISEASE, PERSISTS FOLLOWING DRUG CLEARANCE

Autor: Murray, Joseph A., Wassaf, Dina, Morgan, Stephanie, Kontos, Stephan, Goldstein, Kaela E., Thornley, Tom, Grebe, Kristie M.
Zdroj: In Gastroenterology May 2023 164(6) Supplement:S
Databáze: ScienceDirect